-
Impact of Recurrence Modelling on Cost-Effectiveness of New Treatments for Early Cancers
Mar 10, 2025, 14:00 PM -
The Pen That Makes You Leaner: GLP-1 Prescription Trends for Weight Loss in the US
Mar 10, 2025, 14:00 PM -
Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Health and Economic Value of Pneumococcal Conjugate Vaccine Against Antimicrobial Resistance in Brazil: An Agent-based Simulation Study
Mar 10, 2025, 14:00 PM -
Disparities in Testing for Mismatch Repair Genes Among Medicare Beneficiaries with Colon Cancer: A Claims-Based Analysis
Mar 10, 2025, 14:00 PM -
Can Robotics Narrow the Access Disparities in Minimally Invasive Surgery?
Mar 10, 2025, 14:00 PM -
Evaluation of the Impact of Fezolinetant vs Placebo on Indirect Costs Among Women With VMS Associated With Menopause
Mar 10, 2025, 14:00 PM -
Evaluating the Cost-Effectiveness of Wastewater-Based Disease Surveillance
Mar 10, 2025, 14:00 PM -
Diagnosis and Treatment Journey of Patients With Atrial Fibrillation Prior to Stroke Occurrence
Mar 10, 2025, 14:00 PM -
A Flexible Dynamic Transmission Model Framework for Evaluating Tuberculosis Treatments: Methodological Challenges and Applications
Mar 10, 2025, 14:00 PM -
Analysis of 20 Years of Legislative Trends to Predict Future Investment and Access to Orphan Drugs
Mar 10, 2025, 14:00 PM -
Selection and Stability of Parametric Bivariate Copula Models for Joint Modelling of Overall and Progression-Free Survival
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Axitinib (Caxetib®) as Second-Line Therapy for the Treatment of Metastatic Renal Cell Carcinoma in the National Oncology Institute in Mexico
Mar 10, 2025, 14:00 PM -
Exploring the Impact of Exercise Variability of Mental Health: Results From the 2024 US National Health and Wellness Survey
Mar 10, 2025, 14:00 PM -
Patient's Experience of Crohn's Disease: A Conceptual Model Based on Qualitative Interviews
Mar 10, 2025, 14:00 PM -
Evolving Real-world Trends in Biomarker Testing for Bladder Cancer: A Comprehensive Retrospective Analysis from the US Community Oncology Setting (2015-2024)
Mar 10, 2025, 14:00 PM -
Predictors of Low Disease Activity/ Remission Amongst Rheumatoid Arthritis Patients Experiencing Inadequate Response to Biologic/ Targeted Synthetic Disease-Modifying Antirheumatic Drugs
Mar 10, 2025, 14:00 PM -
Integrating Next Generation Sequencing, EHR, and Claims Data to Extend Follow-Up in a Real-World Advanced Lung Adenocarcinoma Biomarker-Treatment Landscape
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada
Mar 10, 2025, 14:00 PM -
Cost Opportunity of Polatuzumab Vedotin as First-Line Therapy for DLBCL on Subsequent Treatments - Brazilian Cost Analysis
Mar 10, 2025, 14:00 PM
